biostudies-literatureUnknown27(1)Parissenti ABreast cancer research : BCRhttps://www.ebi.ac.uk/biostudies/studies/S-EPMC12337404biostudies-literatureHigh mid-treatment tumour RNA disruption in patients with HER2-negative breast cancer is associated with improved disease-free survival after neoadjuvant chemotherapyPMC12337404Haugen MLingjaerde OParissenti ATheriault GSt-Onge REngebraaten ODahle MGythfeldt HMasilamani TPritzker LD’costa LfalseHigh mid-treatment tumour RNA disruption in patients with HER2-negative breast cancer is associated with improved disease-free survival after neoadjuvant chemotherapy2025-01-01T00:00:00Z2025 Jan2026-05-29T16:34:28.309Z2026-04-08T05:24:57.761ZS-EPMC12337404